Navigation Links
Elbit Imaging Ltd. Announces that InSightec Announces that the FDA has Approved Exablate System for Treatment in the USA
Date:10/7/2015

TEL AVIV, Israel, October 7, 2015 /PRNewswire/ --

Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit" or the "Company") announced today that it was informed by InSightec Ltd. ("InSightec"), that the United States Food and Drug Administration (FDA) has approved InSightec's next generation Exablate system to treat symptomatic uterine fibroids and changed the labeling to allow consideration for women who desire to maintain fertility. The updated labeling specifies that ablation of uterine fibroid tissue can now be considered for women with symptomatic uterine fibroids, who desire to retain fertility and spare their uterus.

InSightec estimates that such change in labeling provides younger women suffering from symptomatic fibroids access to a new, non-invasive treatment option that is safe, effective and keeps their uterus intact without compromising their existing ability to get pregnant. The approval is based on accumulated, documented clinical data on 118 patients' pregnancies post Exablate MRgFUS treatments.

FDA approval of INSIGHTEC's next generation Exablate system offers treating physicians a more advanced technology.

The Company holds approximately 82.7% of the share capital of Elbit Medical Technologies Ltd. ("Elbit Medical") (TASE: EMTC-M) (on a fully diluted basis) which, in turn, holds approximately 29.6% of the share capital in InSightec (on a fully diluted basis).

About Elbit Imaging Ltd. 

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial centers - initiation, construction, and sale of commercial centers and other mixed-use property projects, predominantly in the retail sector, located in Central and Eastern Europe and in India. In certain circumstances and depending on market conditions, the Group operates and manages commercial centers prior to their sale. (ii) Hotels - hotels operation and management. (iii) Medical industries and devices - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment, and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine. (iv) Residential projects - initiation, construction and sale of residential units or plots designated for residential located primarily in India.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 

Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as "believe," "would," "expect," "intend," "estimate" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2014, under the caption "Risk Factors." Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements. 

For Further Information: 

Company Contact

Ron Hadassi
Chairman of the Board of Directors
Tel: +972-3-608-6048
Fax: +972-3-608-6050
ron@elbitimaging.com


'/>"/>
SOURCE Elbit Imaging Ltd.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Elbit Imaging Announces Its Subsidiary, Plaza Centers, Has Announced on an Acquisition of Loan to Control Liberec Plaza in the Czech Republic
2. Elbit Imaging Announces Receipt of a Court Resolution That Schedules the Dates for Written Response and Hearing of the Interim Injunction Motion for Temporary Remedies
3. Elbit Imaging Ltd. Appoints its Chief Financial Officer, Doron Moshe, as Acting CEO
4. Elbit Imaging Ltd. Announces Investment of US$ 12.5 Million in Insightec by Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited
5. Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company
6. Elbit Imaging Announces Gamida Cell Signs Option and Investment Agreements with Major Pharmaceutical Company
7. Elbit Imaging Announces the Results of the Companys Unsecured Financial Creditors Meeting Approving the General Terms of Agreement to be Entered Into With Bank Hapoalim
8. Elbit Imaging Ltd. Announces Results of its General Meeting
9. Elbit Imaging Ltd. Announces (1) Courts Resolution Regarding the Results of Creditors Meeting and (2) Results of Extraordinary General Meeting
10. Elbit Imaging Ltd. Announces First Quarter Results For 2013
11. Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2019)... ... September 17, 2019 , ... Called Muss-Bits (Musical Sensory Substitution Bits) it ... Design Awards Students category. , It was developed by Associate Professor Suranga Nanayakkara and ... is comprised of two parts. A “sensor bit” that can be placed on or ...
(Date:9/17/2019)... ... September 17, 2019 , ... ... to establish a new partnership with NextGen Healthcare Inc., a leading healthcare solutions ... partners, which include Nextech, DrChrono, Symplast and Azalea, with additional partnerships to announce ...
(Date:9/17/2019)... CHERRY HILL, N.J. (PRWEB) , ... September 17, ... ... of Canal Calem Periodontics located in Moorestown and Medford, NJ, now welcome patients ... team of periodontists strives to save natural teeth whenever possible. When tooth removal ...
Breaking Medicine Technology:
(Date:9/11/2019)... , ... September 11, 2019 , ... ... exhibit at the 2019 AHIMA Health Data and Information Conference in Chicago, Illinois ... by booth #505 to learn more about GRM’s healthcare information management solutions ...
(Date:9/11/2019)... ... September 11, 2019 , ... Autopsies don’t lie. ... injury to the body. , Methamphetamine permanently harms the heart. It increases risks ... getting a better understanding of how the damage occurs. , An August ...
(Date:9/11/2019)... ... 2019 , ... Ahipoki is excited to announce a new vegan and gluten ... vegetarians, pescatarians and poke bowl fans alike. Ahimi is made of five simple ... texture similar to tuna, Ahipoki customers will now have a vegan option ...
(Date:9/11/2019)... ... ... Women’s Excellence is excited to announce the opening of their new Royal ... Royal Oak, MI 48073 in the heart of Royal Oak off Woodward Avenue south ... a contemporary, spa-like atmosphere. We are thrilled to be in a great, central ...
(Date:9/11/2019)... , ... September 10, 2019 , ... ... Doctors by Pasadena Magazine. These physicians have been recognized among the best doctors ... pediatric subspecialties:, Robert H. Cho, M.D. – Chief ...
Breaking Medicine News(10 mins):